Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0684249 (
lung carcinoma
)
23,830
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Operations were performed on 3,313 patients for
lung carcinoma
in the Department of Surgery of the Lungs and
Mediastinum
of the National Research Center of Surgery, AMS USSR, from 1963 till 1.01.90. Among these patients 263 (7.9%) were treated by combined operations (resection of the lung together with part of the chest wall, trachea and its bifurcation, pericardium, diaphragm, superior vena cava, pulmonary artery, aorta, and atrium, and also with removal of metastatic lymph nodes of the contralateral lung). Three types of combined resections were carried out--vasculo-atrial, tracheo-bronchial, and parieto-diaphragmatic. Postoperative complications developed in 38.6% of patients. Intraoperative mortality was 1.5%, 13.9% of patients died after the operation. More than 5 years survived 21.8% of patients who underwent operation, more than 10 years 10.2%, and more than 15 years 5.6% of patients.
...
PMID:[Combined resections in the surgery of lung cancer]. 143 53
Repeated uni- and bilateral resections of the lungs conducted from 1963 to 01.01.91 at the Department of Surgery of the Lungs and
Mediastinum
of the National Research Center of Surgery, USSR AMS for primary multiple carcinoma (13 patients) and metastatic lesions (32 patients) accounted for 1.3% of all operations in
lung carcinoma
. Such interventions are more justified in differentiated forms of primary multiple carcinoma and in solitary and occasional metastases of malignant tumors of various localization to the lungs. Morphological signs are the main differential diagnostic criteria of primary multiple carcinoma and intrapulmonary metastases. The main principle of surgical treatment of patients with primary multiple carcinoma and metastatic involvement of the lungs is an economical character of the operation with maximally admissible, from the oncological standpoint, preservation of functionally valuable pulmonary tissue. The combined method of treatment (operation + drug antineoplastic therapy) should take the leading place in the management of patients with intrapulmonary metastases of malignant tumors.
...
PMID:[Repeat uni- and bilateral operations in surgery for multiple primary cancer of the lungs and intrathoracic metastases]. 148 93
In the Department of Surgery of Lungs and
Mediastinum
, National Research Centre of Surgery, USSR AMS, 88 patients underwent operation for
lung carcinoma
extending into the thoracic wall (which accounted for 2.6% of all patients who were operated on for carcinoma of the lungs) from 1963 to December 1990. Surgical treatment of such patients is the method of choice. The performance of both radical and palliative operations is expedient. The survival of patients after operation is determined by the depth of invasion of the thoracic wall by
lung carcinoma
and the condition of intrathoracic lymph nodes.
...
PMID:[Surgical treatment of lung cancer extending into the thoracic wall]. 158 18